Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: kha vu who wrote (39873)	5/13/1999 4:00:00 PM
From: kha vu	Respond to of 120523

biotech news: FDA Grants Matrix Pharmaceutical, Inc. (MATX) Fast Track Status For IntraDose In Head And Neck Cancer -- Stock Up +150.0% On Thursday At 10:20 AM EST Centocor, (CNTO) Johnson & Johnson (JNJ) End Merger Talks, Person Familiar Says La Jolla Pharmaceutical (LJPC) Announces Interim Analysis Of Phase II/III Clinical Trial Of Experimental Lupus Drug -- Stock Off -56.6% On Thursday At 10:15 AM EST Immunex Corporation (IMNX) Ordered By FDA To Do New Enbrel Safety Studies -- Stock Off -3.1% On Thursday At 10:29 AM EST Myriad Genetics (MYGN) Delivers Four Potential Drug Targets To Bayer Corporation; Depression And Dementia Collaboration Added $54.0 Million In Research And Potential Milestones -- MYGN Stock Up +5.6% On Thursday At 9:55 AM EST Trimeris' (TRMS) T-1249, Second HIV Fusion Inhibitor, Receives Fast Track Designation From FDA biospace.com biospace.com biospace.com